Morning Consult, a nonpartisan digital media and research company, has published an op-ed, The RX Rip-off, by Prescription Justice’s Executive Director, Jodi Dart. The op-ed highlights Prescription Justice’s recent poll by Zogby analytics that reveals roughly 79 percent of Americans believe prescription drug prices are too high, and nearly 52 percent believe that pharmaceutical companies engage in price gouging and put profits over patients. The poll also shows that overwhelming majorities support changes that will bring down drug prices, which comes hard on the heels of new Prescription Justice analysis showing 45 million Americans did not fill a prescription last year due to cost.
"By introducing the Affordable and Safe Prescription Drug Importation Act, Sens. Sanders, Booker and Casey have heeded the call of the millions of Americans who struggle each year with the insurmountable costs of prescription drugs " said Jodi Dart, executive director of Prescription Justice. "This legislation will provide new safety protocols and guidance for American consumers who need access to lower cost medications from safe international pharmacies, beginning with Canada. Last year, 45 million Americans did not fill a prescription because of costs, and a recent poll commissioned by Prescription Justice shows overwhelming majorities support changes that will bring down drug prices. President Trump and members of Congress have an opportunity to make good on their promises to lower drug prices for American consumers. We hope they will have the political will and courage to pass this important legislation."
According to a new Zogby Poll, 75% of Americans agree with President Trump that the pharmaceutical industry is “getting away with murder” on drug prices. While Republican members of Congress have prioritized the dismantling of Obamacare, the majority of Americans, both Republican and Democrats alike, are clearly concerned about prescription drug costs. The poll shows that 79 percent of Americans believe drug prices are too high, while nearly 52 percent believe the pharmaceutical industry is price gouging and putting profits over patients.
Today, Prescription Justice issued a press release announcing new data showing that 45 million Americans did not fill a prescription in 2016 because of drug costs and the publication of its policy report recommending that President Donald Trump take executive actions to help consumers more easily import lower cost medications for personal use. Previously, Prescription Justice reported that 35 million American adults did not fill a prescription because of cost. The new data, extracted from the Commonwealth Fund’s 2016 International Health Policy Survey of Adults, shows the crisis of high drug prices to be worse than is widely reported.
We are proud to announce that we have changed our organization’s (DBA) name from Prescription Justice Action Group to Prescription Justice, which is a simpler expression of our core position: making prescription drugs affordable is an issue of justice for Americans and we will help them obtain it.